Results 231 to 240 of about 836,777 (260)
Some of the next articles are maybe not open access.

Advancements in pancreatic neuroendocrine tumors

Expert Review of Gastroenterology & Hepatology, 2013
Pancreatic neuroendocrine tumors (PanNETs) have increased in incidence in the USA over the last 20 years. Although PanNETs are often misconceived as being indolent tumors as they have a far more favorable prognosis over pancreatic adenocarcinoma, roughly 60-70% of patients have metastatic disease at the time of diagnosis due to presentation late in the
Miral R, Sadaria   +2 more
openaire   +2 more sources

Medical Management of Pancreatic Neuroendocrine Tumors

The American Journal of Gastroenterology, 2008
Pancreatic neuroendocrine tumors (PNET) are rare malignancies frequently diagnosed at a late stage, with symptoms related to bulky disease. Hormonal secretion, when responsible for symptoms, permits, on the other hand, early diagnosis of the disease. Surgery remains the cornerstone of therapeutic management.
Delaunoit, Thierry   +4 more
openaire   +3 more sources

Non-Functioning Pancreatic Neuroendocrine Tumors

2015
Nonfunctioning pancreatic neuroendocrine tumors are quite rare, representing 2 % of all pancreatic malignancies and 85 % of all pancreatic neuroendocrine tumors. They are classified based on the Ki-67 labeling index as “tumors” when Ki-67 is 20 %. On a molecular basis, they are different from pancreatic adenocarcinoma, expressing menin-1, death domain-
Anna Koumarianou, Nicola Fazio
openaire   +1 more source

Pancreatic Neuroendocrine Tumors

2007
Neuroendocrine tumors of the pancreas are uncommon neoplasms. They may occur as a sporadic lesion or as part of a genetic disease such as the multiple endocrine neoplasia type 1 (MEN-1) syndrome. Sporadic tumors usually arise as a single lesion, whereas those associated with familial disorders generally are multifocal.
Erik-Jan Wamsteker, James M. Scheiman
openaire   +1 more source

Management of Pancreatic Neuroendocrine Tumors

Gastroenterology Clinics of North America, 2012
Daniel M, Halperin, Matthew H, Kulke
openaire   +2 more sources

Cystic pancreatic neuroendocrine tumor

Gastrointestinal Endoscopy, 2010
David L, Diehl   +2 more
openaire   +2 more sources

Pancreatic Neuroendocrine Tumors

2023
Leonardo P. Marcal   +3 more
openaire   +2 more sources

Sunitinib and Everolimus in Pancreatic Neuroendocrine Tumors

Tumori Journal, 2012
Giuseppe Procopio   +2 more
openaire   +2 more sources

Advances in Pancreatic Neuroendocrine Tumor Treatment

New England Journal of Medicine, 2011
Castellano, Daniel   +2 more
openaire   +6 more sources

Home - About - Disclaimer - Privacy